Nuvation Bio Inc (NUVB)
3.25
-0.08
(-2.40%)
USD |
NYSE |
May 10, 16:00
3.245
0.00 (0.00%)
After-Hours: 20:00
Nuvation Bio Enterprise Value: 100.69M for May 10, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 10, 2024 | 100.69M |
| May 09, 2024 | 118.21M |
| May 08, 2024 | 94.12M |
| May 07, 2024 | 87.54M |
| May 06, 2024 | 85.35M |
| May 03, 2024 | 94.12M |
| May 02, 2024 | 105.07M |
| May 01, 2024 | 89.73M |
| April 30, 2024 | 43.74M |
| April 29, 2024 | 34.97M |
| April 26, 2024 | -24.17M |
| April 25, 2024 | -37.31M |
| April 24, 2024 | -28.55M |
| April 23, 2024 | -24.17M |
| April 22, 2024 | -24.17M |
| April 19, 2024 | -41.69M |
| April 18, 2024 | -46.07M |
| April 17, 2024 | -21.98M |
| April 16, 2024 | 4.307M |
| April 15, 2024 | 19.64M |
| April 12, 2024 | 39.35M |
| April 11, 2024 | 78.78M |
| April 10, 2024 | 56.88M |
| April 09, 2024 | 96.31M |
| April 08, 2024 | 96.31M |
| Date | Value |
|---|---|
| April 05, 2024 | 109.45M |
| April 04, 2024 | 151.07M |
| April 03, 2024 | 183.92M |
| April 02, 2024 | 144.50M |
| April 01, 2024 | 197.07M |
| March 28, 2024 | 186.12M |
| March 27, 2024 | 258.40M |
| March 26, 2024 | 19.64M |
| March 25, 2024 | -118.36M |
| March 22, 2024 | -105.22M |
| March 21, 2024 | -120.55M |
| March 20, 2024 | -190.64M |
| March 19, 2024 | -173.12M |
| March 18, 2024 | -116.17M |
| March 15, 2024 | -111.79M |
| March 14, 2024 | -131.50M |
| March 13, 2024 | -83.31M |
| March 12, 2024 | -100.84M |
| March 11, 2024 | -87.69M |
| March 08, 2024 | -76.74M |
| March 07, 2024 | -65.79M |
| March 06, 2024 | -87.69M |
| March 05, 2024 | -133.69M |
| March 04, 2024 | -146.84M |
| March 01, 2024 | -122.74M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-408.36M
Minimum
Oct 31 2023
2.955B
Maximum
Mar 19 2021
341.49M
Average
-67.25M
Median
Enterprise Value Benchmarks
| iBio Inc | 16.31M |
| Flora Growth Corp | 12.22M |
| Lixte Biotechnology Holdings Inc | 5.054M |
| Replimune Group Inc | -28.42M |
| ABVC BioPharma Inc | 12.27M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -13.79M |
| Total Expenses (Quarterly) | 20.83M |
| EPS Diluted (Quarterly) | -0.07 |
| Earnings Yield | -10.77% |